DK398683A - Fremgangsmaade til fremstilling af antistoffer - Google Patents

Fremgangsmaade til fremstilling af antistoffer Download PDF

Info

Publication number
DK398683A
DK398683A DK398683A DK398683A DK398683A DK 398683 A DK398683 A DK 398683A DK 398683 A DK398683 A DK 398683A DK 398683 A DK398683 A DK 398683A DK 398683 A DK398683 A DK 398683A
Authority
DK
Denmark
Prior art keywords
antibodies
procedure
mammal
vaccine
manufacturing antibodies
Prior art date
Application number
DK398683A
Other languages
English (en)
Other versions
DK398683D0 (da
Inventor
Margaret Anneli Linggood
Philip Porter
Jonathan Richard Powell
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Nv filed Critical Unilever Nv
Publication of DK398683D0 publication Critical patent/DK398683D0/da
Publication of DK398683A publication Critical patent/DK398683A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C11/00—Milk substitutes, e.g. coffee whitener compositions
    • A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
    • A23C11/10—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins
    • A23C11/103—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins containing only proteins from pulses, oilseeds or nuts, e.g. nut milk
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
    • A23L11/60—Drinks from legumes, e.g. lupine drinks
    • A23L11/65—Soy drinks
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • C07K16/1232—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Agronomy & Crop Science (AREA)
  • Botany (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK398683A 1982-09-02 1983-09-01 Fremgangsmaade til fremstilling af antistoffer DK398683A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8225036 1982-09-02

Publications (2)

Publication Number Publication Date
DK398683D0 DK398683D0 (da) 1983-09-01
DK398683A true DK398683A (da) 1984-03-03

Family

ID=10532644

Family Applications (1)

Application Number Title Priority Date Filing Date
DK398683A DK398683A (da) 1982-09-02 1983-09-01 Fremgangsmaade til fremstilling af antistoffer

Country Status (12)

Country Link
EP (1) EP0102831B1 (da)
JP (2) JPS5973528A (da)
AT (1) ATE43500T1 (da)
AU (1) AU548623B2 (da)
CA (1) CA1219806A (da)
DE (1) DE3379937D1 (da)
DK (1) DK398683A (da)
GB (1) GB2126236B (da)
HK (1) HK91087A (da)
IE (1) IE55673B1 (da)
NZ (1) NZ205392A (da)
ZA (1) ZA836349B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK219084D0 (da) * 1984-05-02 1984-05-02 Frederik Carl Peter Lindberg Antigen
JPS6399020A (ja) * 1986-06-05 1988-04-30 ベイラ−　カレツジ　オブ　メデイシン ワクチンとその製法
US4725435A (en) * 1986-06-18 1988-02-16 Bactex, Inc. Vaccine composition for immunization against urinary tract infection caused by E. coli
US5106618A (en) * 1987-07-02 1992-04-21 Stolle Research And Development Corporation Method of treating protozoal gastrointestinal disorders by administering hyperimmune milk product
AU601510B2 (en) * 1987-11-06 1990-09-13 Immunomed Corporation Preparation of bacterium pili subunits and vaccines containing pili subunits
DE4026365A1 (de) * 1990-08-21 1992-02-27 Biotest Pharma Gmbh Sterilfiltrierte kolostralmilch
ATE234855T1 (de) * 1993-09-20 2003-04-15 Anadis Ltd Verfahren zur herstellung von immunoglobulinen aus colostrum und deren verwendung in pharmazeutischen zusammensetzungen
ES2076895B1 (es) * 1994-02-04 1996-08-16 Ind Farma Especial Fimbrias-adhesinas de tipo 1 y p aisladas de nuevas cepas de e. coli, procedimiento para su obtencion y aplicaciones.
US6471966B1 (en) 1994-02-04 2002-10-29 Industrial Farmaceutica Y De Especialidades, S.A. Type 1 and type p fimbriae-adhesins isolated from novel e. coli strains, process for their preparation and uses thereof
US5707678A (en) * 1995-04-12 1998-01-13 Galagen Inc. Method for microfiltration of milk or colostral whey
US5670196A (en) * 1995-04-12 1997-09-23 Galagen Inc. Method for microfiltration of milk or colostral whey
DE19641466A1 (de) * 1996-10-09 1998-04-16 Biotest Pharma Gmbh Orale Anwendung eines Immunglobulinpräparates zur Prävention des Hämolytischen Urämischen Syndroms sowie Präparat hierfür
JP2006506991A (ja) 2002-11-25 2006-03-02 デン・コンゲリエ・ヴェテリネー−オ・ランボホイスコレ ブタ多型およびその検出のための方法
AU2003901008A0 (en) * 2003-03-04 2003-03-20 Anadis Ltd Composition for the treatment and prevention of bacterial infections

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1472624A (en) * 1974-09-02 1977-05-04 Canadian Patents Dev Enteric disease vaccine
GB1560934A (en) * 1975-05-07 1980-02-13 Unilever Ltd Methods for the resistance of non-human mammals to gastro-intestinal disorders
JPS5842759B2 (ja) * 1975-05-23 1983-09-21 カブシキガイシヤ バイオリサ−チセンタ− セルラ−ゼノセイゾウホウ
GB1553664A (en) * 1975-06-12 1979-09-26 Unilever Ltd Antigenic compositions
JPS52120116A (en) * 1976-04-02 1977-10-08 Kitasato Inst Domestic animal colitis germ inactevated vaccine
CH627079A5 (en) * 1977-04-15 1981-12-31 Nestle Sa Process for preparing a protein concentrate containing immunological factors of milk origin
EP0048881B1 (en) * 1980-09-15 1985-08-28 Bactex Incorporated Immunization of humans against enterotoxogenic infection by escherichia coli
JPS5781417A (en) * 1980-09-15 1982-05-21 Bactex Inc Human immunity effect imparting vaccine against escherichia coli infectious desease
JPS5784147A (en) * 1980-11-13 1982-05-26 Seiko Epson Corp Manufacture of integrated circuit

Also Published As

Publication number Publication date
EP0102831B1 (en) 1989-05-31
AU1853883A (en) 1984-03-08
GB2126236A (en) 1984-03-21
GB8323455D0 (en) 1983-10-05
DE3379937D1 (en) 1989-07-06
AU548623B2 (en) 1985-12-19
CA1219806A (en) 1987-03-31
IE832055L (en) 1984-03-02
NZ205392A (en) 1987-03-06
GB2126236B (en) 1986-09-24
IE55673B1 (en) 1990-12-19
EP0102831A1 (en) 1984-03-14
ATE43500T1 (de) 1989-06-15
JPS5973528A (ja) 1984-04-25
JPH02160726A (ja) 1990-06-20
HK91087A (en) 1987-12-11
ZA836349B (en) 1985-04-24
DK398683D0 (da) 1983-09-01

Similar Documents

Publication Publication Date Title
DK398683A (da) Fremgangsmaade til fremstilling af antistoffer
EP0077734A3 (en) Production of monoclonal antibodies against bacterial adhesins
ATE229978T1 (de) Helicobacter proteine und impstoffe
DK6081A (da) Fremgangsmaade til fremstilling af et bakteriepraeparat
DK388384A (da) Monoklone antistoffer med specifitet for membran-associerede antigener, deres fremstilling og anvendelse
GR3005768T3 (da)
CA2022420A1 (en) Escherichia coli vaccine
FI882707A7 (fi) Menetelmä ja valmiste maidon proteiinipitoisuuden lisäämiseksi.
ES477212A1 (es) Un procedimiento para la preparacion de una enterotoxina.
DE3884680D1 (de) Äusseres Membranprotein F von Pseudomonas aeruginosa.
BG47034A3 (bg) Метод за получаване на 7-//мета-заместени/-пеницилини/- -1-карба-1-детиацефалоспорини
NO920331D0 (no) Biologisk preparat samt bruk derav
DE58908428D1 (de) Sekretormutante von Escherichia coli.
ES2121755T3 (es) Fraccion de caseina para uso terapeutico, profilactico y/o diagnostico en infecciones del tracto respiratorio.
AU2032988A (en) A genus-specific listeria antigen identified by monoclonal antibodies
NO900992D0 (no) Fremgangsmaate for fremstilling av en drikk med en ph-verdi av 3,6 til 4,2 og paa basis av usyrnet melk.
DE69823638D1 (de) Oralprodukt zur Prävention und Behandlung von ansteckender Gastroenteritis in Kälbern
DK183788D0 (da) Fremgangsmaade til foroegelse af levedygtigheden af frysetoerrede, maelkesyreproducerende bakteriekulturkoncentrater
BR9814556A (pt) Cepas isoladas de staphylococcus aureus e vacinas fabricadas a partir das mesmas
FI894048A0 (fi) Menetelmä Pseudomonas aeruginosa-infektioita vastaan vaikuttavien valmisteiden sekä immunoglobuliini-G-pitoisten, Pseudomonas aeruginosa-bakteeria vastaan vaikuttavien valmisteiden tuottamiseksi
CA2347278A1 (en) Vaccine based on attenuated haemophilus somnus
Dubeikovskaya et al. Use of ELISA for detecting specific antibodies to Pseudomonas aeruginosa in patients with acute and chronic pulmonary diseases.
Vitkov et al. Antigenic structural studies of S. aureus strains in mastitis in cows
Yan et al. Study on the relationship between the ability to utilize lactose and antigenicity of Sh. flexneri type I, II isolated from patients.
NO891704D0 (no) Transformerte melkesyrebakterier.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment